ENOV · Enovis Corp
United States · RS rating 22 · As of 2026-10-14
| Price | 18.57 USD |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 22 / 86 / 10 / 18 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 18 / 33 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | +8.9% |
| Sales growth Q/Q | +4.9% |
| Distance from 52-week high | +43.5% |
| Market cap (USD) | $1.3B |